Carl Zeiss Meditec AG (XSWX:AFX) Cyclically Adjusted PS Ratio: (As of Jul. 04, 2026)


XSWX:AFX Carl Zeiss Meditec AG XSWX:AFX
67 GF Score
Price CHF25.86
GF Value CHF65.76
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Carl Zeiss Meditec AG Cyclically Adjusted PS Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PS Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Carl Zeiss Meditec AG  (XSWX:AFX) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Carl Zeiss Meditec AG Cyclically Adjusted PS Ratio Related Terms


Carl Zeiss Meditec AG Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Carl Zeiss Meditec AG's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carl Zeiss Meditec AG Cyclically Adjusted PS Ratio Chart

Carl Zeiss Meditec AG Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.31 6.39 4.47 3.60 1.99

Carl Zeiss Meditec AG Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.27 2.97 2.75 1.99 1.88

XSWX:AFX vs ISRG, BDX, MDLN: Cyclically Adjusted PS Ratio Comparison

For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carl Zeiss Meditec AG Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Carl Zeiss Meditec AG's Cyclically Adjusted PS Ratio falls into.


XSWX:AFX
67GF Score
Carl Zeiss Meditec AG XSWX:AFX
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Carl Zeiss Meditec AG Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Carl Zeiss Meditec AG's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2025 is calculated as:

For example, Carl Zeiss Meditec AG's adjusted Revenue per Share data for the three months ended in Dec. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=5.336/129.3606*129.3606
=5.336

Current CPI (Dec. 2025) = 129.3606.

Carl Zeiss Meditec AG Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201603 3.719 100.017 4.810
201606 3.407 100.717 4.376
201609 3.947 101.017 5.054
201612 3.703 101.217 4.733
201703 4.031 101.417 5.142
201706 3.394 102.117 4.299
201709 4.142 102.717 5.216
201712 3.865 102.617 4.872
201803 4.192 102.917 5.269
201806 4.054 104.017 5.042
201809 4.417 104.718 5.456
201812 4.071 104.217 5.053
201903 4.361 104.217 5.413
201906 4.517 105.718 5.527
201909 5.235 106.018 6.388
201912 4.473 105.818 5.468
202003 4.084 105.718 4.997
202006 3.025 106.618 3.670
202009 4.493 105.818 5.493
202012 4.478 105.518 5.490
202103 4.954 107.518 5.960
202106 5.338 108.486 6.365
202109 5.422 109.435 6.409
202112 4.731 110.384 5.544
202203 5.073 113.968 5.758
202206 5.482 115.760 6.126
202209 6.121 118.818 6.664
202212 5.187 119.345 5.622
202303 5.560 122.402 5.876
202306 5.841 123.140 6.136
202309 6.258 124.195 6.518
202312 5.031 123.773 5.258
202403 5.102 125.038 5.278
202406 5.783 125.882 5.943
202409 6.249 126.198 6.406
202412 5.250 127.041 5.346
202503 6.137 127.779 6.213
202506 5.820 128.412 5.863
202509 6.724 129.255 6.729
202512 5.336 129.361 5.336

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Carl Zeiss Meditec AG (XSWX:AFX) Overvalued in 2026?

Based on GuruFocus' analysis, Carl Zeiss Meditec AG stock appears to be undervalued. The current stock price of CHF25.86 is trading 60.7% below its estimated GF Value™ of CHF65.76. GuruFocus considers Carl Zeiss Meditec AG to be Significantly Undervalued.

Key valuation signals for XSWX:AFX:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: CHF65.76 vs. price of CHF25.86 (60.7% below fair value)
  • GF Score™: 67/100 with 4 warning signs

No single metric tells the full story. See the XSWX:AFX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Carl Zeiss Meditec AG Business Description

Address Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
67GF Score

Get the complete analysis for XSWX:AFX

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF25.86
Price
CHF65.76
GF Value